ALternate Site Cardiac ReSYNChronization (ALSYNC) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 138 participants.

Also called NCT01277783

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 138 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01277783
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium, Canada, France, Hungary, Italy, Netherlands, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01277783. Allocation not applicable; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2019-06-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ALternate Site Cardiac ReSYNChronization (ALSYNC) Study
Acronym
ALSYNC
Condition
Heart Failure
Intervention (Device)
Endocardial Left Ventricular pacing
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct01277783
Content hash
a1e665935f2d33957b9181fb4d0da0851a84dcc9a714e099265ae7db64f3c799